RT @JorgensenWL: It is very sad to learn that Martin Karplus passed away on Dec 28 at age 94. He was a scholar and pioneering chemical phys….

🟦 During the promotion event you can access all three search modes of infiniSee xREAL for free! Enough time to test its capacities in your projects. 🟦 Get a 10% on all compounds retrieved from xREAL till November 30.

Access 2.4 trillion of drug-like molecules with infiniSee xREAL!.We are excited to release the terminal to Enamine Ltd. largest compound catalog that efficient mines the most relevant molecules based on the needs of the drug discovery project. Enter xREAL:

We have an exclusive launch offer to share!. No commitment, no strings attached. Just pure, unfiltered access to trillions of compounds for 3 Months!. Don't miss out on this limited-time opportunity! ⌛.

Launch promotion:.🟦 Access to all three search modes during the event.🟦 Discount on all compounds retrieved from the xREAL Space.

BioSolveIT and @EnamineLtd are excited to announce infiniSee xREAL: Your access point to the largest catalog of drug-like compounds. 🟦 Exclusive access.🟦 2.4 trillions of compounds.🟦 Screen from your own hardware.

You will also have the chance to engage with industry professionals and other participants at the Happy Hour to unwind and exchange perspectives during networking. There is also a possibility to participate virtually if you want to tune in from somewhere else.

Amount of available in-person seats is limited, so please be fast to register!.Register following the link 🔺.

We cordially invite all drug hunters from the Boston Area, molecule enthusiasts and participants of the Fragment-Based Lead Discovery Conference to join a collaborative Chemical Space exploration workshop taking place on September 25th, 2024, in Boston from 2:30 pm to 5:00 pm.

BioSolveIT x eMolecules workshop in Boston (September 25, 2024) on:.🔹 1️⃣ Kinase inhibitor design.🔹 2️⃣ Fragment-based drug discovery.🔹 3️⃣ Scaffold hopping.🔹 4️⃣ PROTACs.🔹 5️⃣ Chemical Space Docking™. #compchem #medchem #FBDD.

New guest, new challenge: Episode #2 of "What The Drug!?" is coming up!.Let's see how much we can achieve this time and leap into yet maybe unexplored drug discovery areas. Save-the-date: Wed, 14 Aug 2024, 16:00 CEST (Berlin).Register following the link 🔻.

‼️ Important announcement: The beta testing stage for Chemical Space Docking ends August 31st, 2024 ‼️.Chemical Space Docking allows you to perform efficient, in-house hit candidate assessment of billions or even trillions on your own hardware.

The increasing interest in designing drugs that covalently bind to their target can hardly be neglected. This spreadsheet features 36 of the most common covalent warheads used in medicinal chemistry as well as their bound form after transformation. SeeSAR:

Our next webinar highlights the new features of the most recent release of the drug discovery software platforms SeeSAR and infiniSee. We will talk about sophisticated covalent docking, Chemical Space exploration and much more. July 11 4pm Berlin Time.

Here is your quick rundown on the just-released infiniSee 6.1 update:.🟦 R group search in the Motif Matcher.🟦 Generation of ad hoc libraries.🟦 Support of semi-metals (Ge, As, Sb, Te).🟦 Distinct similarity columns in the Analyzer Mode.🟦 And many more.

The library is offered free-of-charge on our website and can be used right after download in SeeSAR or the command-line version of FastGrow.

Derived from our validated set, users now have access to the most diverse catalog of anchoring fragments for ideation and optimization. Use cases involve sampling of motif replacements, improvement of ADME properties and screening for 3D guided scaffold hops for novel IPs.

A powerhouse for kinase inhibitor design: We are proud to release a fragment growing library containing over 51k potential hinge binder motifs. #compchem #medchem #drugdiscovery #drugdesign #CADD.

The most sophisticated covalent docking out there features convenient transformation of 36 most commonly used warheads in drug discovery. Read more about the covered warheads, handling of stereochemistry and available customization 🔻. #compchem #medchem.

Gazing at ML-193, a GPR55 antagonist: This GPCR ligand displays nanomolar inhibition with an improved selectivity profile over other related receptors. Furthermore, a total of three Chemical Spaces feature ML-193 as an exact match, among other relevant compounds in the remaining.